The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines

C. de Jong, M. Wittmann, D. Jelusic, M. Schuler, H. Alma, T. van der Molen, K. Schultz (Groningen, Netherlands; Bad Reichenhall, Würzburg, Germany)

Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Session: Non inflammatory monitoring of airway diseases
Session type: Poster Discussion
Number: 3011
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. de Jong, M. Wittmann, D. Jelusic, M. Schuler, H. Alma, T. van der Molen, K. Schultz (Groningen, Netherlands; Bad Reichenhall, Würzburg, Germany). The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines. Eur Respir J 2014; 44: Suppl. 58, 3011

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
GOLD assessment of COPD patients: Impact of symptoms assessment choice
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012

New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
Source: Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Year: 2013

Characterization of patients with COPD GOLD stage I and II referred for pulmonary rehabilitation
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015

Comparison of CAT and mMRC in evaluating clinical symptoms co-morbidity and medical resource utilization in COPD patients
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014

Responsiveness of the clinical COPD questionaire to pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013


Assessment of patients with COPD according to previous and new GOLD: Which stage in which group?
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


Physician attitudes toward questionnaires and indices for COPD.Results of On-Sint study
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002

Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014


Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1)
Year: 2013


The association between objective CT measures of bronchiectasis and health-related quality of life in COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014

Discordant symptom severity in COPD: The PHAROAH study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015


Measurement of COPD’s impact using the COPD assessment test (CAT) and symptom assessment differences between patients and family members
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013

Predictive role of mMRC scale on quality of life in COPD patients
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Development of the Manchester early morning symptoms index in COPD
Source: International Congress 2014 – COPD physiopathology
Year: 2014


The frequency of exacerbations in COPD patients and its influence on the effects of pulmonary rehabilitation
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014


Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Does the effectiveness of pulmonary rehabilitation vary in patients with different baseline severity of symptoms classified by MRC grade?
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Response of the COPD assessment test (CAT) to short-term inpatient pulmonary rehabilitation
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013